{"id":"W2150952126","doi":"10.1016/s0140-6736(08)60453-5","title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","year":2008,"lang":"en","type":"article","venue":"The Lancet","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1403,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"Chugai Pharmaceutical","keywords":"Tocilizumab; Medicine; Rheumatoid arthritis; Placebo; Internal medicine; Clinical endpoint; Rheumatology; Methotrexate; Population; Randomized controlled trial; Arthritis; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}